Announcements Trials
Browse Landscape

Phase

Phase 2 88Phase 1 56Phase 1/2 50Phase 3 26Phase EARLY_PHASE1 2Phase 4 2Phase NA 1Phase 2/3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Genitourinary 1

Conditions

Melanoma 5Kidney Neoplasms 4Carcinoma, Renal Cell 4Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 2Thoracic Neoplasms 1Skin Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Lung Diseases 1Liver Neoplasms 1

Interventions

Pemetrexed 10Cisplatin 9Erlotinib Hydrochloride 8Carboplatin 7icotinib 5Gefitinib 5Docetaxel 5endostar protein 3Zoledronic Acid 3Radiotherapy 3Paclitaxel 3Gemcitabine 3Endostatins 3Afatinib 3tislelizumab 2pembrolizumab 2osimertinib 2lorlatinib 2flurbiprofen axetil 2dexamethasone 21-phosphate 2atezolizumab 2Vinorelbine 2Surgical Procedures, Operative 2Saline Solution 2Nivolumab 2Drug Therapy 2Dexamethasone 2Chemoradiotherapy 2trametinib 1spartalizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Carcinoma, Non-Small-Cell Lung × Nivolumab × Clear all
NCT03444766 2020-12-04

Study of Nivolumab for Advanced Cancers in India

Bristol-Myers Squibb

Phase 4 Completed
100 enrolled 12 charts
GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms

NCT04331626 2020-04-02

Low-dose Gemcitabine Combined With Nivolumab for Second-line and Above Line Treatment of NSCLC

Henan Cancer Hospital

Phase 4 Unknown
50 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡